Warner developed XRpro® Technology and founded Caldera Pharmaceuticals. He has a background in chemical synthesis and molecular recognition. He holds a PhD from the Massachusetts Institute of Technology.
Lori Peterson, COO.
Peterson is a molecular and genetic epidemiologist who previously worked at the National Institutes of Health ~ National Cancer Institute, the American Cancer Society HQ, the Centers for Disease Control and Prevention, MD Anderson, and Fred Hutchinson Cancer Center. She has a background in disease etiology and prevention. She holds an MS in Molecular Genetics from Texas A&M, MPH in Cancer Epidemiology from the University of Washington and PhD training in Environmental Medicine from the University of Texas in Houston.
XRpro® drug discovery technology
Caldera pioneered high-throughput, label-free XRpro® drug discovery technology. XRpro® allows the screening of tens of thousands of protein-drug interactions per day with no modifications to either the drug candidate or the protein/target.
XRpro® eliminates costly and error-inducing chemical labels and provides data that more closely approximates in vivo drug behavior.
Copyright 2012 Caldera Pharmaceuticals, Inc.
All rights reserved.
Caldera Pharmaceuticals, Inc. 278-D DP Road, Los Alamos, NM 87544 175 W. Jackson #2230, Chicago, IL 60604 ph: 505-661-2420 fax: 302-347-1326 email@example.com